Funded Tech Companies
Allogene Therapeutics
Allogene Therapeutics is a biopharmaceutical company, located in San Francisco. Financial backing was provided by Fidelity Management & Research Company, Jennison Associates and Deerfield Capital.
Company Overview
Company Name
Allogene Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
210 E Grand Ave.
San Francisco, CA 94080
USA
San Francisco, CA 94080
USA
Phone
Website
Email Address
Company Background Information
Overview
Allogene Therapeutics is a biotechnology company with a mission to catalyze the next revolution in cancer treatment through the development of allogeneic chimeric antigen receptor T-cell (CAR T) therapy directed at blood cancers and solid tumors.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/10/2018
Financing History
Management Team
Title
Name
Email & Social
Chairman
Arie Belldegrun
Chief Executive Officer
David Chang
Chief Financial Officer
Eric Schmidt
Chief Scientific Officer
Barbra Sasu
Chief Technical Officer
Alison Moore
Vice President
David Tillett
VP - Bus. Development
Susie Jun
VP - General Counsel
Veer Bhavnagri
Company Investors
- Fidelity Management & Research Company
- Jennison Associates
- Deerfield Capital
- venBio
- Perceptive Advisors
- T. Rowe Price
- Franklin Templeton
- Surveyor Capital
- Vida Ventures
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs